Home › Atherosclerosis › Virginia › Norfolk
Atherosclerosis clinical trials in Norfolk, VA
3 studies for Atherosclerosis are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- York Clinical Research, Norfolk
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Tidewater Kidney Specialists, Norfolk
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Norfolk
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Durham, NC7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- The Woodlands, TX6 studies
Other studies in Norfolk
- Breast Cancer15 studies
- Bladder Cancer8 studies
- Prostate Cancer8 studies
- Non-Small Cell Lung Cancer7 studies
- Abdominal Aortic Aneurysm7 studies
- Heart Failure7 studies
- Cancer (all types)7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Triple-Negative Breast Cancer5 studies
- Peripheral Arterial Disease5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.